comparemela.com

Latest Breaking News On - Galimedix inc - Page 1 : comparemela.com

Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer s Disease

Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer s Disease
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Investegate |Secarna Pharmaceuticals GmbH & Announcements | Secarna Pharmaceuticals GmbH &: Secarna Pharmaceuticals appoints Alexander Gebauer, MD, PhD as CEO and Managing Director

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Personnel Secarna Pharmaceuticals appoints Alexander Gebauer, MD, PhD as CEO and Managing Director 04.02.2021 / 14:00 Secarna Pharmaceuticals appoints Alexander Gebauer, MD, PhD as CEO and Managing Director Munich/Martinsried, Germany, February 04, 2021 - Secarna Pharmaceuticals GmbH & Co. KG ( Secarna ), a biopharmaceutical company focusing on the discovery and development of next generation antisense oligonucleotide (ASO) therapies to address challenging or previously undruggable targets via its LNAplus TM platform, announced today that the Company has appointed Alexander Gebauer, MD, PhD as CEO and Managing Director. Dr. Gebauer brings more than 25 years of experience in the pharmaceutical and biotechnology industry in leadership roles in North America, Europe and India. His focus has been on R&D, from early discovery up to launch and life cycle management, as well as business development and designing and impl

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.